Spectrum of activity:
|
Gram-negative
|
Details of activity:
|
Active against Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae; at <25uM concentration it acts as an antivirulence agent (binds to GalU which is involved in lipopolysaccharide core region synthesis), at higher concentrations acts as membrane-active agent
|
Description:
|
Synthetic compound; known inhibitor of signal transducers and activators of transcription (STAT3); shows synergistic effect with kanamycin, ampicillin, chloramphenicol, gentamicin, and spectinomycin
|
Institute where first reported:
|
School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China
|
Year first mentioned:
|
2023
|
Development status:
|
Experimental
|